Electrical Stimulation for Learning and Memory in Alzheimer's and Primary Progressive Aphasia
This trial will test if a non-invasive brain stimulation technique can improve verbal learning in Alzheimer's patients.
- Nonfluent Aphasia
- Progressive Aphasia
- Alzheimer's Disease
- Primary Progressive Aphasia
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Frequently Asked Questions
How many participants are allowed to enroll in this research endeavor?
"Indeed, the information available on clinicaltrials.gov attests to this study's ongoing recruitment process. This trial was first posted in August 1st 2020 and its most recent update happened July 8th 2022; it is searching for 60 patients from a single site."
Is the eligible age range for this trial above or below 65 years?
"This study only allows participants aged 50 to 75, in accordance with their eligibility criteria."
Would I be qualified to join this research endeavor?
"This research endeavour is aiming to enroll 60 individuals with Alzheimer's Disease between the ages of 50 and 75. Furthermore, participants must pass the following prerequisites: have a minimum high-school education, be right-handed, fit the Mild Cognitive Impairment or 'possible AD' designation according to 2011 guidelines while also having corresponding biomarkers such as cerebrospinal fluid or PET scans that demonstrate amyloid-beta deposits/FDG uptake with unihemispheric atrophy."
Are there still slots available for individuals to partake in this research?
"According to clinicaltrials.gov, this patient recruitment is ongoing, with the original post dating back to August 1st 2020 and a recent edit on July 8th 2022."
What are the key objectives of this medical study?
"This study seeks to quantify changes in auditory recall accuracy and syntactic comprehension, as well as spatial span forward score and verbal fluency task scores. Evaluations will be taken at baseline, directly after intervention, one month post-intervention and three months post-intervention up until a total of 31 weeks have elapsed. Improvements in the measured metrics are seen as beneficial outcomes for participants enrolled in this trial."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Average response time
- < 2 Days
Most responsive sites:
- Johns Hopkins Hospital: < 24 hours